Company Profile
Labyrinth Biotech is a precision oncology company based in Suzhou Industrial Park, advancing cancer diagnostics through AI-powered liquid biopsy and rare cell technologies.
Our 26-member team and expert advisors—many with backgrounds from Fortune 500 pharmaceutical companies and leading institutions such as Yale, Harvard, MIT, and Peking University—bring deep expertise in precision medicine, microfluidics, and data-driven healthcare.
Backed by over 40 patents (20+ granted) and operating under NMPA, FDA, CE, and ISO 13485 standards, we deliver scalable, non-invasive solutions to enable personalized, real-time cancer care worldwide.
Growth & Development
Mission and Vision
To transform cancer diagnostics through Al-powered CTCliquid biopsy technologies-delivering accurate, real-time,and non-invasive solutions for early detection and treatment monitoring across China and beyond.
To lead the global shift toward precision oncology by making CTC-based liquid biopsy the new clinical standard-bridging cutting-edge science with scalable impact across healthcare systems worldwide.
Scientific Advisor
Cooperation Partners
Honor
1st Prize Award Certificate, China Medical Device Innovation Competition 2019
1st Prize Trophy, 2019 China Medical Device Innovation Competition
SIP Jinji Lake Technology Leading Talent
The 2024 Future Medical Top 100 Selection Medical and Health Industry Innovation Product List
National High-Tech Enterprise
Jiangsu Private Science & Technology Enterprise
Jiangsu Provincial Innovative SME
Patent